No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial
暂无分享,去创建一个
L. Hegedüs | G. Daniels | S. Sherman | R. Tuttle | R. Tuttle | S. Rasmussen | B. V. von Scholten | J. D. Karsbøl
[1] J. Buse,et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.
[2] John B Buse,et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.
[3] L. Hegedüs,et al. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations , 2015, Diabetes, obesity and metabolism.
[4] T. O'Dorisio,et al. Medical management of metastatic medullary thyroid cancer , 2014, Cancer.
[5] B. Zinman,et al. Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. , 2013, American heart journal.
[6] Afsar Barlas,et al. GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. , 2012, Endocrinology.
[7] L. Hegedüs,et al. GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide. , 2011, The Journal of clinical endocrinology and metabolism.
[8] K. Almholt,et al. Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. , 2010, Endocrinology.
[9] C. Sekulla,et al. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. , 2009, Endocrine-related cancer.
[10] Sebastiano Filetti,et al. Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls , 2009, Nature Clinical Practice Endocrinology &Metabolism.
[11] R. Elisei. Routine serum calcitonin measurement in the evaluation of thyroid nodules. , 2008, Best practice & research. Clinical endocrinology & metabolism.